Despite their challenging nature, cell & gene therapies (CGTs) are becoming ever more successful and accessible one-time treatments for haematological malignancies and genetic diseases, while researchers have recently made significant strides forward in their use to treat other cancers.

Read now to discover: 

• How new innovations and investment are supporting CGT market growth

• Whether tumour-infiltrating lymphocyte therapy (TIL) can be applied to cold solid tumours

• The arrival of potentially revolutionary gene therapies for epilepsy 

 

Brought to you by